Quantcast

Latest AstraZeneca Stories

2014-09-16 12:31:25

SAN FRANCISCO, Sept. 16, 2014 /PRNewswire/ -- Nektar Therapeutics (NASDAQ:NKTR) reported today that partner AstraZeneca today announced that the US Food and Drug Administration (FDA) approved MOVANTIK((TM)) (naloxegol) tablets as the first once-daily oral peripherally-acting mu-opioid receptor antagonist (PAMORA) medication for the treatment of opioid-induced constipation (OIC), in adult patients with chronic, non-cancer pain. Opioids play an important role in chronic pain relief...

2014-09-16 08:29:21

INDIANAPOLIS, Sept. 16, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and AstraZeneca today announced an agreement to co-develop and commercialize AZD3293, an oral beta secretase cleaving enzyme (BACE) inhibitor currently in development as a potential treatment for Alzheimer's disease. The progression of Alzheimer's disease is characterized by the accumulation of amyloid plaque in the brain. BACE is an enzyme associated with the development of beta-amyloid. Inhibiting BACE...

2014-09-15 08:26:00

The makers of FluMist® Quadrivalent (Influenza Vaccine Live, Intranasal) and the "CSI: Cyber" star launch national campaign to dispel common misconceptions about flu and annual vaccination WILMINGTON, Del., Sept. 15, 2014 /PRNewswire/ -- AstraZeneca announced today that it has collaborated with actor and father James Van Der Beek on a campaign to dispel common myths about the flu and underscore the importance of annual influenza vaccination for eligible individuals and families. As...

2014-09-12 16:24:47

WASHINGTON, Sept. 12, 2014 /PRNewswire/ -- Syngenta today responded to the lawsuit filed against Syngenta Seeds, Inc. in Louisiana state court by Cargill. Syngenta believes that the lawsuit is without merit and strongly upholds the right of growers to have access to approved new technologies that can increase both their productivity and their profitability. The Agrisure Viptera(®) trait (MIR162) was approved for cultivation in the U.S. in 2010. Syngenta commercialized the trait...

2014-09-12 12:22:13

- "Right to Grow" program offers U.S. farmers corn rootworm control and a stewardship premium for Agrisure Duracade corn planted in 2015 MINNETONKA, Minn., Sept. 12, 2014 /PRNewswire/ -- Syngenta announced today that it has renewed and enhanced its program with Gavilon Grain, LLC, to provide grain marketing opportunities for U.S. farmers who plant Agrisure Duracade(TM) in 2015. Agrisure Duracade is Syngenta's cutting-edge corn rootworm (CRW) control technology approved in the U.S....

2014-09-11 23:02:32

New research report “Global Intranasal Drug Delivery Market & Pipeline Insight” worked out by Kuick Research is now available at MarketPublishers.com. London, UK (PRWEB) September 11, 2014 The emergence of intranasal drug delivery as an essential method of delivering drugs recently has been largely driven by its potential and capability to cure chronic allergies and local infections. The scientists and researchers have found out a variety of advantages and benefits of utilising...

2014-09-11 20:21:43

Clinical oncology expert joins as company advances late-stage clinical programs BOULDER, Colo., Sept. 11, 2014 /PRNewswire/ -- Array BioPharma Inc. (NASDAQ: ARRY), a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients with cancer, today announced the appointment of Victor Sandor, M.D., as Chief Medical Officer. Dr. Sandor will be responsible for leading clinical, medical and regulatory strategy and...

2014-09-07 08:20:28

MarketOptimizer.org adds new report "Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023" to its store. Overview of ACS, including epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines as well as an overview on the competitive landscape. DALLAS, Sept. 7, 2014 /PRNewswire-iReach/ -- New PharmaPoint Drug Evaluation report, "Cangrelor (Acute Coronary Syndrome) - Forecast and Market Analysis to 2023". The current ACS market - primarily comprised of...

2014-09-05 08:24:15

FREMONT, Calif., Sept. 5, 2014 /PRNewswire/ -- Ardelyx, Inc. (NASDAQ: ARDX), a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal and metabolic diseases, today announced that Dominique Charmot, Ph.D., the Company's Chief Scientific Officer, has announced his retirement from Ardelyx, effective December 23, 2014. Dr. Charmot cited personal reasons for his departure, including his desire to spend more time with his family. "Dominique has been a vital...

2014-09-05 08:22:57

BEIJING, Sept. 5, 2014 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced a new presentation time for the Aegis Healthcare & Technology Conference, to be held at the Wynn Las Vegas on September 12, 2014. Management will present at 8:00 am PT. Please contact your Aegis representative to schedule a meeting with the Company. About Sinovac Sinovac Biotech Ltd. is a China-based biopharmaceutical company that...


Word of the Day
malpais
  • The ragged surface of a lava-flow.
'Malpais' translates from Spanish as 'bad land.'